ISOXAZOLYL-PYRIMIDINES AS INHIBITORS OF SRC AND LCK PROTEIN KINASES
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP1417205A1
公开(公告)日:2004-05-12
US6689778B2
申请人:——
公开号:US6689778B2
公开(公告)日:2004-02-10
[EN] ISOXAZOLYL-PYRIMIDINES AS INHIBITORS OF SRC AND LCK PROTEIN KINASES<br/>[FR] ISOXAZOLYL-PYRIMIDINES UTILISEES EN TANT QU'INHIBITEURS DES PROTEINES KINASES SRC ET LCK
申请人:VERTEX PHARMA
公开号:WO2003004492A1
公开(公告)日:2003-01-16
The present invention provides compounds of formula I or a pharmaceutically acceptable derivative thereof, wherein A-B is N-O or O-N and G, R?1, R2, R3, and R4¿ are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of Src and Lck kinase. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.